id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2026-P-5611-0003,FDA,FDA-2026-P-5611,attachment-1-orange-book-page,Supporting & Related Material,Background Material,2026-05-14T04:00:00Z,2026,5,,,2026-05-14T23:37:59Z,,0,0,09000064b92d874f
FDA-2026-P-5611-0004,FDA,FDA-2026-P-5611,attachment-2-rld-labeling,Supporting & Related Material,Background Material,2026-05-14T04:00:00Z,2026,5,,,2026-05-14T23:38:03Z,,0,0,09000064b92d8750
FDA-2026-P-5611-0005,FDA,FDA-2026-P-5611,attachment-3-test-product-draft-labeling,Supporting & Related Material,Background Material,2026-05-14T04:00:00Z,2026,5,,,2026-05-14T23:38:07Z,,0,0,09000064b92d8751
FDA-2026-P-5611-0002,FDA,FDA-2026-P-5611,"Acknowledgment Letter from FDA DMB to Senores Pharmaceuticals, Inc",Other,Acknowledgement Letter/Receipt,2026-05-14T04:00:00Z,2026,5,2026-05-14T04:00:00Z,,2026-05-14T23:37:28Z,,0,0,09000064b92d7cce
FDA-2026-P-5611-0001,FDA,FDA-2026-P-5611,"Suitability Petition from Senores Pharmaceuticals, Inc",Other,Petition(s),2026-05-14T04:00:00Z,2026,5,2026-05-14T04:00:00Z,,2026-05-14T23:37:18Z,,1,0,09000064b92d9592